Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Essential,Hypertension”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00654875
What this trial is testing

Efficacy and Safety of Once Daily Dosing of Aliskiren (300 mg (qd) Once a Day) to Twice Daily Dosing of Aliskiren (150 mg (Bid) Twice a Day) in Treating Moderate Hypertension.

Who this might be right for
Essential Hypertension
Novartis 328
Post-approval studies (Phase 4)UnknownNCT05917275
What this trial is testing

Multi-Omics to Predict the Blood Pressure Response to Antihypertensives

Who this might be right for
Primary Hypertension
Radboud University Medical Center 96
Large-scale testing (Phase 3)Not Yet RecruitingNCT07083765
What this trial is testing

Renal Artery Denervation Assessment Without Antihypertensive Medication Regimen (RADAR)

Who this might be right for
HypertensionHypertension,Essential
Ablative Solutions, Inc. 202
Testing effectiveness (Phase 2)Study completedNCT01264692
What this trial is testing

Essential Hypertension

Who this might be right for
Essential Hypertension
Idorsia Pharmaceuticals Ltd. 196
Not applicableUnknownNCT02772315
What this trial is testing

Omics Signature in the Diagnosis of Hypertension

Who this might be right for
Hypertension
Radboud University Medical Center 4,000
Not applicableUnknownNCT04863508
What this trial is testing

Wearable Blood Pressure Devices to Identify Masked Uncontrolled Hypertension.

Who this might be right for
Hypertension,EssentialHypertension, Masked
National Taiwan University Hospital Hsin-Chu Branch 90
Not applicableNot Yet RecruitingNCT06520800
What this trial is testing

Treatment and Handling Severe Obesity-Related Comorbidities in Adolescents Through Exercise

Who this might be right for
Adolescent ObesityHypertension,EssentialNon-Alcoholic Fatty Liver Disease+3 more
University of Lisbon 24
Large-scale testing (Phase 3)Study completedNCT02722265
What this trial is testing

Long-term Study of CS-3150 as Monotherapy or in Combination With Other Antihypertensive Drug in Japanese Patients With Essential Hypertension

Who this might be right for
Essential Hypertension
Daiichi Sankyo Co., Ltd. 368
Testing effectiveness (Phase 2)Active Not RecruitingNCT07835971
What this trial is testing

Evaluate Efficacy and Safety of GW906 in Patients With Essential Hypertension

Who this might be right for
Hypertension
Shenzhen Salubris Pharmaceuticals Co., Ltd. 319
Early research (Phase 1)Study completedNCT00937534
What this trial is testing

Study to Compare and Assess the Safety and Pharmacokinetic Characteristics After Oral Administration of Fimasartan (BR-A-657∙K) in Healthy Elderly and Young Male Volunteers

Who this might be right for
Essential Hypertension
Boryung Pharmaceutical Co., Ltd 22
Not applicableNot Yet RecruitingNCT07717996
What this trial is testing

Smartphone-Guided Paced Breathing and Aerobic Exercise for Essential Hypertension

Who this might be right for
Essential (Primary) Hypertension
Cairo University 75
Large-scale testing (Phase 3)Not Yet RecruitingNCT06716970
What this trial is testing

QR12000 Compound Tablets in Patients with Moderate to Severe Essential Hypertension

Who this might be right for
Essential Hypertension
Wuhan Createrna Science and Technology Co., Ltd 810
Large-scale testing (Phase 3)Ended earlyNCT00447603
What this trial is testing

Losartan Compared to Losartan/HCTZ in Pediatric Patients With Hypertension (0954A-327)

Who this might be right for
Hypertension
Organon and Co 40
Large-scale testing (Phase 3)Study completedNCT00394823
What this trial is testing

VALIDATE Valsartan and Supportive Measures - Impact on Drug Adherence of Treated Hypertensive Patients

Who this might be right for
Hypertension
Novartis 206
Not applicableStudy completedNCT01195805
What this trial is testing

The Effects of Amiloride and Spironolactone on Renophysiological and Cardiovascular Variables

Who this might be right for
Essential Hypertension
Regional Hospital Holstebro 25
Large-scale testing (Phase 3)Looking for participantsNCT06647745
What this trial is testing

A Randomized, Double-blind, Multi-center, Active-controlled, Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of THP-00101, THP-00102, and THP-00103 in Subjects With T2DM and Essential Hypertension

Who this might be right for
Type 2 DiabetesHypertension
THPharm Corp. 221
Post-approval studies (Phase 4)Study completedNCT00698646
What this trial is testing

Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Compared to Valsartan Monotherapy or Hydrochlorothiazide Monotherapy in Elderly (>70) With Mild-moderate Hypertension.

Who this might be right for
Hypertension
Novartis Pharmaceuticals 384
Not applicableStudy completedNCT04459741
What this trial is testing

HIV, Immune Activation and Salt Sensitive Hypertension

Who this might be right for
HIV-1-infectionHypertension,Essential
Mulungushi University 85
Testing effectiveness (Phase 2)Study completedNCT03503773
What this trial is testing

The TARGET BP OFF-MED Trial

Who this might be right for
HypertensionHypertension,Essential
Ablative Solutions, Inc. 350
Post-approval studies (Phase 4)Study completedNCT02398929
What this trial is testing

BRAVE Study With Uncontrolled Essential Hypertension (BRAVE Study)

Who this might be right for
Hypertension
Chinese University of Hong Kong 100
Next Page